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From genomic association studies, quantitative trait loci analysis, and epigenomic mapping,
it is evident that significant efforts are necessary to define genetic-epigenetic interactions
and understand their role in disease susceptibility and progression. For this reason, an anal-
ysis of the effects of genetic variation on gene expression and DNA methylation in human
placentas at high resolution and whole-genome coverage will have multiple mechanistic
and practical implications. By producing and analyzing DNA sequence variation (n = 303),
DNA methylation (n = 303) and mRNA expression data (n = 80) from placentas from healthy
women, we investigate the regulatory landscape of the human placenta and offer analytical
approaches to integrate different types of genomic data and address some potential limita-
tions of current platforms. We distinguish two profiles of interaction between expression and
DNA methylation, revealing linear or bimodal effects, reflecting differences in genomic con-
text, transcription factor recruitment, and possibly cell subpopulations. These findings help
to clarify the interactions of genetic, epigenetic, and transcriptional regulatory mechanisms
in normal human placentas. They also provide strong evidence for genotype-driven modifi-
cations of transcription and DNA methylation in normal placentas. In addition to these
mechanistic implications, the data and analytical methods presented here will improve the
interpretability of genome-wide and epigenome-wide association studies for human traits
and diseases that involve placental functions.
Author summary
The placenta is a critical organ playing multiple roles including oxygen and metabolite
transfer from mother to fetus, hormone production, and vascular perfusion. With this
study, we aimed to deliver a placenta-specific regulatory map based on a combination of
publicly available and newly generated data. To complete this reference, we obtained
genotype information (n = 303), DNA methylation (n = 303) and expression data (n = 80)
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for placentas from healthy women. Our analysis of methylation and expression quantita-
tive trait loci (QTLs) and correlations between methylation and expression data were
designed to identify fundamental associations between genome, transcriptome, and epi-
genome in this key fetal organ. The results provide high-resolution genetic and epigenetic
maps specific to the placenta based on a representative ethnically diverse cohort. As inter-
est and efforts are growing to better understand the etiology of placental disease and the
impact of the environment on placental function these data will provide a reference and
enhance future investigations.
Introduction
Functional genomic approaches using combinations of genomic, epigenomic and transcrip-
tomic data can define regulatory landscapes and provide a basis for biomarker discovery and
insights into disease etiology. Advances in sequencing technologies have resulted in a surge in
the number and complexity of multi-omics datasets, providing unprecedented opportunities
to map the regulatory landscape, while imposing substantial analytical challenges. Increasingly,
researchers acknowledge the limited usefulness of genome-wide approaches that examine a
single component of transcriptional regulation in isolation and appreciate the growing impor-
tance of “multi-omic” analyses. Indeed, genomic sequence variation, epigenetic and post-
translational regulators are interdependent and jointly contribute to the normal functioning
or dysfunction of a tissue, calling for integrative approaches to fully appreciate the interactions
between these different layers of regulation.
Originally two main lines of investigation were pursued—association studies and molecular
quantitative trait loci (QTL) analysis. Association studies aim to identify traits associated with
genetic variants (Genome Wide Association Studies, GWAS) and more recently traits associ-
ated with changes in DNA methylation (Epigenome Wide Association Studies, EWAS). Over
the past decades, thousands of common genetic variants associated with specific diseases or
phenotypes have been cataloged [1–3]. Building on the GWAS model, EWAS rapidly became
a fast-growing area of research [4]. However, these discovery approaches provide limited
insights into causal mechanisms. To address these limitations, QTL analyses have been imple-
mented linking genetic variants with changes in expression (eQTL), DNA methylation
(mQTL; alternatively abbreviated as meQTL) or other transcriptional regulatory mechanisms.
Catalogs of thousands of tissue-specific and shared regulatory eQTL variants at high resolu-
tion, such as in the Genotype Tissue Expression (GTEx) catalog, provide insights into the
diversity and regulation of gene expression across various tissues [5]. Although cytosine meth-
ylation varies with sex, age or exposure to environmental factors [6] and changes in methyla-
tion patterns have been associated with many common diseases [7], DNA methylation is also
under strong genetic influence, and locus-specific methylation levels are often correlated in
related individuals [8, 9]. Twin studies provide additional evidence of the underlying genetic
effect on DNA methylation pattern [9, 10] and it has been estimated that more than 30% of the
methylation variance can be attributed to genotype [11].
More directly, genetic variants and haplotypes have been shown to influence local DNA
methylation patterns, most often in cis. Loci, where DNA methylation is under genetic control,
are known as methylation quantitative trait loci (mQTL). The physical counterpart of cis-act-
ing mQTLs, which can be directly scored by bisulfite sequencing (bis-seq; methyl-seq) is hap-
lotype-dependent allele-specific methylation (hap-ASM). We (CD, BT) have previously
characterized mQTLs and hap-ASM in multiple human tissue types, including T lymphocytes
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and brain cells, as well as a small series of placentas [12, 13]. In that work, we noted that an
analysis of a larger independent series of placentas was in progress, which is represented by the
current study.
Unlike most other human tissue types, the number of genome-wide–omic level studies
involving placentas is relatively limited with placenta being absent from most initiatives such
as the GTEx consortium or the GWAS database. However, in view of its critical role, there is
growing interest in better understanding the impact of placenta malfunctions throughout fetal
life. During a key developmental window, the placenta controls fetal access to nutrients, hor-
mone production and mitigation of adverse effects from the environment, with placental dys-
function resulting in chronic diseases such as heart disease, type 2 diabetes or cancer [14–17].
Evidence suggests that such perturbations of the intrauterine environment alter the appropri-
ate genetic programming and disrupt placental and fetal development [18–20]. Although there
is strong support for changes in DNA methylation to be involved, a direct association between
environmental conditions, methylation alterations, and gene expression is difficult to confirm.
The unique function of the placenta is reflected through its unique transcriptome and methy-
lome profiles. In a previous study, Storvik et al. [21] showed a relatively poor correlation in
term of transcriptome between placenta and 34 other tissues based on microarray data with
many mRNA and miRNA species specific to the placenta. Similarly, as previously shown by
our group and others, the mean genome-wide level of DNA methylation across placentas is
lower than that found in other tissues, with an increased representation of low and intermedi-
ate levels [13, 22]. Such singularities emphasize the need for specific investigations of the pla-
centa regulatory landscape. Along these lines, Peng et al. [23] performed an eQTL study using
159 placentas. They examined correlations between GWAS data and the newly identified
eQTLs and found evidence for eQTLs potentially driving postnatal disease susceptibility, sup-
porting the Developmental Origins of Health and Disease (DOHaD) hypothesis. These find-
ings confirm the need for a thorough characterization of the placenta regulatory landscape,
preferably not limited to genetic variant and gene expression.
Among the potential limitations of mQTL and eQTL studies are subpopulation effects, cell
specificity, genetic background or genomic context, as many factors that need to be accounted
for to achieve reproducibility and accuracy. Further challenges include the integration of mul-
tiple types of data calls for quality control assessments, independent controls for both false-
positive and false-negative findings, and a limited understanding of stochastic variation in the
different signals. Finally, the availability of a reference dataset is key to support ongoing func-
tional genomics analysis. However, the cell dependent aspect of transcriptional regulation
does not allow for direct carryover of findings from one tissue or cell type to another. Lack of
ethnic and racial diversity can also be a limitation, with the most comprehensive studies up to
date involving predominantly Caucasian populations [24–26].
These considerations have motivated the present study where we set out to generate essen-
tial reference data sets of genotypes, gene expression, and DNA methylation patterns, based on
a representative population of placentas; an understudied yet important tissue. In addition, we
aimed to develop stringent analytical methods to serve as a blueprint for future studies. We
intensively characterized the effects of genetic variation on gene expression (eQTLs) and DNA
methylation (mQTLs) and developed a comprehensive approach to identify methylation-sen-
sitive transcription (abbreviated here as expression-relevant Quantitative Trait Methylation;
eQTM) in normal human placentas. We emphasize technical caveats, independent validations,
and consideration of both false-positive and false-negative findings. Our integrative multi-
omic approach provides a multilayered view of gene regulation influenced by common genetic
variants in the human placentas, thus providing a basis for future advances in individualized
medicine.
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Results
Cohort information
Actual functional genomics studies are suffering from the overrepresentation of Caucasian
backgrounds, which limit the reproducibility of the findings in more heterogeneous and repre-
sentative populations. Aware of this limitation, it was important to characterize the ancestral
history of our population to confirm the mix-population background of our cohort and to
identify outliers that should be excluded from further analysis. We performed local ancestry
deconvolution using PCA analysis based on the reference population using genotype data
from the 1000 Genomes Project from Caucasians (CEU), Africans (YRI) and East Asians
(CHB + JPT). Our data showed a clear clustering to populations, with some enrichment for
mixed populations represented as expected (S1C Fig) validating the use of our cohort as a rep-
resentative cohort for control placenta samples.
To assure the relevance of our human placenta cohort as representative of ‘normal’ individ-
uals, we used quality control measures to assess the impact of variability in the datasets. Sample
heterogeneity was estimated running Pearson’s correlation across expression and methylation
data. Global correlation among our samples ranges between 0.92 and 0.99 for expression val-
ues and between 0.93 and 0.99 for DNA methylation values (S1A and S1B Fig). As correlation
can be artificially over-estimated when interrogating large datasets with extreme values, fur-
ther analysis aimed at selecting those genes and loci with greater variability. Variability was
estimated using median absolute deviation (MAD) as previously described [27]. After assign-
ing a variability score to each interrogated CpG or transcript, variability was divided using
quartile distribution creating 4 categories: no variability, low, medium and high variability.
Loci and transcripts from the 4th quartile of variability (high) were used to run correlation
using a similar approach and range from 0.75 to 0.96 for expression values and from 0.64 to
0.98 for DNA methylation values. Principal Component Analysis (PCA) was then used to
describe variability across samples and link variability to known covariates including batch
effects, biological and clinical cofactors. As expected, the batch of sequencing is contributing
to most of the variability in both expression and methylation datasets (S2 Fig). Interestingly,
when focusing on the principal component accounting for most of the variability, we also
found a significant association with preeclampsia status and mode of delivery in both datasets
(S2 Fig). However, our approach still suffers from limitations as it only provides us with infor-
mation on known confounders. For example, even though all samples were taken from the
same region of the placentas (Methods), heterogeneity in tissue composition likely exists and
could influence inter-sample variability but is not reflected in this analysis.
Transcriptome and methylome profiles in human placenta
The placenta presents a unique transcriptome and methylome profile as demonstrated by the
poor correlation in term of transcriptomic profiles between placenta and 34 other tissues
based on microarray data [21]. Among these tissues, the lung was the most like placenta and
liver showed the weakest correlation. Because microarrays do not query the full extent of the
transcriptome, we decided to perform a similar correlation analysis using RNAseq data com-
paring placenta transcriptomes from our study with transcriptomes of the 53 available tissues
from the GTEx consortium. For each tissue, we considered median TPM values across samples
and only processed genes that were expressed (TPM>0.1) across each tissue type. The correla-
tion scores ranged from 0.02 to 0.27 reflecting a high diversity between placenta and the other
tissues (S1 Table). Interestingly, among the tissues overlapping between the GTEx consortium
and the one tested by Storvik et al., we confirmed lung as being closest to the placenta and
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liver to be the one with the weakest correlation. The mean genome-wide level of DNA methyl-
ation across placentas is lower than that found in other tissues, with an increased representa-
tion of low and intermediate levels [13, 22].
High variability in DNA methylation has been studied in CD34+ hematopoietic stem and
progenitor cells [27] and proposed as a marker that can help localize key regulatory elements
involve in cell-lineage commitment and cell specific functions. Therefore, we decided to fur-
ther investigate genes with increased variability in expression or DNA methylation levels
across samples and to look for associated pathways. As described above, gene and CpG were
classified based on their variability across samples using MAD. We then focus on the top 500
variable genes or CpGs and performed pathways enrichment analysis (S2 and S3 Tables). Tra-
ditional gene set enrichment analysis (GSEA) does not take into account the physical charac-
teristics of the gene and has been shown to be biased by factors such as the length of the gene
[28]. To address this, we used the Bioconductor package GOseq [29] developed to control for
variability of the length of genes. For each CpG, the closest associated gene was considered.
For the CpG analysis, we adapted the original version of GOseq to control for the number of
probes by gene instead of gene length, as length is not relevant in this case. Interestingly, in
both datasets, the majority of the pathways (S4 Table) were related to the immune response
involving genes from the HLA family suggesting that heterogeneity among samples could be
driven by a different level of inflammations in each placenta. Looking only at expression data,
the top pathway is KEGG "ECM-receptor interaction". ECM related genes have been previ-
ously associated with placental development [30] and have been shown to be correlated with
oxygen tension and nutrient availability [31]. Therefore, variability in the expression for these
pathway-associated genes may reflect various in utero exposures with impact on placenta
development and potential long term consequences even in the absence of clear phenotype at
birth.
Expression and methylation quantitative trait loci in human placenta tissue
To generate maps of associations between genetic variants and gene expression or CpG meth-
ylation patterns specific to the human placenta, we performed eQTL and mQTL analysis
across 1,374,581 SNPs, 23,003 genes, and 485,578 CpG sites respectively. We focused on iden-
tifying cis-eQTLs within windows of 1 Mb between the gene transcription start site (TSS) and
each SNP. QTL tools identified 28,906 significant associations with 1,916 preserved after per-
mutations, which was further reduced to 985 eQTLs after exclusion of associations that failed
the quality threshold (Methods and Fig 1, S3 Fig). A complete list is of the 985 eQTLs used for
further analysis is provided in S5 Table. For mQTL analysis, we focused on 150 kb windows
(75 kb upstream and downstream of the CpG site) as it has been previously published that
mQTLs correlate best with SNPs within 1–2 kb and that most mQTLs are located within 100
kb in several tissues including placenta [13, 32, 33]. 471,852 significant associations were called
using our pipeline, only 105,031 associations pass the permutation test with 4,342 mQTLs con-
served for further analysis (Fig 1, S3 Fig) after stringent exclusions based on quality threshold
(see Methods) and potential probe artifacts. The 4,342 mQTL associations kept for further
analysis are recapitulated in S6 Table.
Some genetic variants that appear as individual differences in methylation can act trivially
via SNPs that create or abolish CpGs (CpG-SNPs) [34] or via technical artifacts due to incom-
plete probe binding [34] or probe-cross reactivity [35] referred to here as “at risk-probe”.
Incomplete probe binding may suggest the presence of a genetic variant within the probe bind-
ing site with greater impact in the proximity of the 3’ end of the binding probe with differences
in signal intensity persisting for up to an approximately 20 bp [36]. Therefore, to make our
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lists more stringent, we identified and excluded associations involving probes that contain
known SNPs, along with probes previously identified as cross-reactive. A list of excluded
probes is in S7 Table. As we illustrate by independent validations below, this high level of strin-
gency is expected to reduce false-positives. Additionally, it can simultaneously give rise to
false-negative findings, particularly for loci queried by probes that contain internal SNPs with
modest minor allele frequencies and/or those without strong effects on probe binding, which
can yield accurate readouts in most samples.
By using a reference-based approach, identification of probes sensitive to CpG-SNPs may
be subject to tissue and sample specificity. Recently, a methodology has emerged to identify “at
risk” probes independently of reference datasets, based on a clustered distribution of methyla-
tion scores [36]. Using this approach, the authors were able to identify a significant number of
“gap probes” that largely overlap with CpG-SNP probes. However, as SNP-affected probes can
exist without gap signatures, the implementation of this reference free approach should be
considered in complement with the reference-based approach. To be as inclusive as possible,
we applied the “gap-hunter” [36] approach to our datasets to identify remaining probes and
associations subject to possible technical artifacts. By doing so, we were able to detect 10,971
“gap probes”. From these, 3,235 are overlapping with previously identified CpG-SNPs probes
and 205 with cross-reactive probes. Finally, 432 of the remaining “gap probes” overlap with
our 4,342 mQTL associations and 158 overlap with our eQTM associations. These probes were
not excluded from further analysis but were annotated following the recommendation of
Andrews et al. [36] (S6 and S7 Tables).
Interestingly, after FDR correction, about 22% of the mQTL (23,043 out of 105,031)
involved an association between an at-risk probe and genetic variant. We are aware that this
proportion reflects in part the stringency of our criteria for exclusion. However, these findings
are strong enough to encourage for stringent criteria when running genome-wide analysis. To
take into consideration false-negative results, it is particularly attractive to use annotation
instead of direct exclusion, as we have used previously [13], and in part adopted here.
Fig 1. Identification of eQTLs and mQTLs. Q-Q plot representing expected versus observed significance for the association
between gene expression and genetic variant (A) and between CpG methylation and genetic variant (B).
https://doi.org/10.1371/journal.pgen.1007785.g001
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Reproducibility of QTL associations
To assess the robustness of our approach we were first interested in looking into the overlap
between our newly identified associations and published data on the human placenta. Because
identification of the causal genetic variant is still challenging due in part to linkage disequilib-
rium, overlaps based on genetic variants are likely to not be as informative. Therefore, we
decided to look at overlap driven by gene or CpG for eQTL and mQTL associations respec-
tively. A recent study published by Peng et al. [23] has identified 3,218 eQTLs associations
based on 159 human placenta tissues. These data represent a unique opportunity to assess data
reproducibility by examining the number of associations preserved across different cohorts.
Our 985 eQTL associations represent 615 unique genes and 62% of them overlap with genes
previously identified by Peng et al. (S8 Table). As noted above, we (CD, BT) previously
reported a list of mQTLs in placentas from a smaller group of samples [13], independent of the
current series. Using more lenient criteria for probe exclusions, we identified 866 mQTLs
(n = 665 with similar exclusion criteria). Among these mQTLs, 319 (~48%) were also found in
the current series, with many of the non-overlapping “hits” reflecting probes on the 450K
methylation arrays that were excluded from the current study (S9 Table). The significance of
these overlaps was further confirmed using a permutation test (n = 1,000). The significance of
the enrichment was defined by the overlap between observed versus expected distribution.
Here, the null distribution represents a random sampling from the total number of annotated
Refseq genes or CpGs interrogated by the Illumina 450K platform. Random permutations
failed to replicate such overlap with a maximum of 17% overlapping genes and 2% overlapping
CpGs. Therefore, we feel confident in the strength of our study and believe that these newly
identified associations represent a solid foundation for further exploration.
After demonstrating a significant overlap for placenta in different cohorts, we were inter-
ested in evaluating the overlap across tissue types. The GTEx Project, assessing and cataloging
eQTLs across more than 40 tissues, is a valuable resource for studying human gene expression
regulation and its relationship to genetic variation across tissue types. However, among the list
of tissues in the GTEx project, the placenta has so far been missing. Therefore, our current
study represents a key opportunity to expand the GTEx exploratory work toward this crucial
fetal organ. To evaluate to what extent the placenta eQTLs replicated the significant SNP-gene
pair eQTLs found in the GTEx study (at FDR<5%) we used the π1 statistic. The π1 statistic
can be interpreted as the fraction of eQTL associations shared between the placenta and the
other tissues available through GTEx. This approach allowed us to identify placenta-specific
eQTLs, and identify tissues with similarity to the placenta in this respect. Levels of significance
were collected across the different tissues for our list of significant eQTL association from the
placenta. π1 value range from 0.31 for the brain cerebellar hemisphere tissue to 0.69 for the
transformed fibroblast cells (S4 Fig, S10 Table). It is interesting to note the absence of interde-
pendence between gene expression correlation and number of conserved eQTLs. Indeed, no
significant overlap was found (Fisher’s exact test, p.value = 0.5935) when overlapping the most
similar tissues to the placenta (n = 10) based on π1 value (S10 Table) with the most similar tis-
sues to the placenta (n = 10) based on gene expression correlation value (S1 Table). Among the
985 eQTL associations identified in placenta, 63 appear to be specific to placenta as not found
significant in any other GTEx tissues (S11 Table). When looking at the genes associated with
these 63 eQTLs we were not able to identify enriched pathways. Unfortunately, similar curated
reference doesn’t exist for mQTL associations with only a limited number of tissue types stud-
ied (brain, blood, lymphoblastoid cells, T-cells and lung [37–42]). Contrary of the GTEx ana-
lytical design, there was no consensus on how associations were defined increasing variability
across studies, a likely confounder when assessing the biological relevance of the overlap.
Functional genomic characterization of the human placenta
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Evaluation of stringency thresholds by bisulfite sequencing
In this study, we used a conservative approach to minimize false positive by excluding probes
with potential cross-reactivity or mapping of common SNPs within 20 bp of the queried CpG,
which might affect the probe hybridization. This stringent approach will reduce false-positives,
but it can also lead to false-negative findings in which bona fide mQTLs are discarded. To
investigate this aspect directly, we applied targeted bisulfite sequencing (bis-seq) to assess
allele-specific CpG methylation (ASM), which is the physical counterpart of mQTLs. For this
purpose, we chose three loci that passed our current stringent criteria for inclusion of the 450K
probes and showed mQTLs (ranking from 82 to 1900 in strength, see S6 and S7 Tables), and
four loci for which the probes were excluded by the current criteria but were included by our
more lenient criteria and showed mQTLs in our prior study of the smaller placental series
[13]. While the net methylation at the index CpGs showed more inter-individual variability in
the bis-seq data, the average net methylation matched that observed in 450K arrays (+/- 5%)
suggesting no or mild hybridization issues with the four excluded Illumina probes. Further,
statistically significant ASM, affecting from 22% to 45% of the heterozygous samples, was
found at the amplicon level for all 7 loci (S12 Table and Fig 2, S5 and S6 Figs), thus validating
these loci as genuine mQTLs.
These data indicate that our stringent criteria for excluding Illumina probes, while mini-
mizing false-positives, can also lead to false-negative findings from exclusion of probes that
are, in fact, legitimately informative. Based on these findings, we conclude that an optimal
approach for harvesting and interpreting mQTLs using Illumina arrays is to annotate each
probe as meeting either stringent or lenient criteria for predicted reliability, and include this
information as a descriptor in comprehensive lists of mQTLs. Here we adopt this approach for
reporting mQTLs (S6 and S13 Tables), but for our bioinformatic enrichment and pathway
analyses, we have used only the mQTLs that pass our stringent probe selection criteria.
Characterization of gene expression and DNA methylation patterns
associated with genetic variants
Characterizing gene expression and DNA methylation patterns that are influenced by genetic
variants can potentially provide functional information about disease-causing genes and path-
ways. Therefore, we were interested in better characterizing genes (n = 615) and CpG sites
(n = 4,324) associated with eQTLs and mQTLs. First, we aimed to assess correlations between
level of expression or level of DNA methylation with genetic variants. Genes were first assigned
to different categories of expression from not expressed to highly expressed using quartiles
based on our placental RNA-seq dataset. A similar approach was applied for DNA methylation
levels. Enrichments for specific quartiles of expression or DNA methylation were assessed by
permutation as described in Methods. The significance of the enrichment was defined by the
overlap between observed versus expected distribution. In these cases, null distribution repre-
sents a random sampling from the total number of annotated Refseq genes or CpGs interro-
gated by the Illumina 450K platform. eQTL associations were found significantly enriched for
genes with intermediate and high level of expression (Fig 3). Such enrichment has been previ-
ously reported in other tissues than placenta by the GTEx consortium [5]. By comparing the
profile of expression between genes associated and genes non-associated to eQTLs, they
showed a shift toward high expression for associated genes across tissue types. mQTL associa-
tions were enriched for CpGs with intermediate levels of DNA methylation (Fig 3). This pat-
tern is likely to reflect on the placenta specific methylation profile with enrichment for low and
intermediate DNA methylation levels. This can also explain the limited range of variation in
DNA methylation across the different genotypes found in our selected mQTLs (with a
Functional genomic characterization of the human placenta
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Fig 2. mQTL validation. Targeted bis-seq data showing Hap-ASM in LRWD1 region. The bis-seq amplicon covers 289 bp
including the mQTL index CpG queried in Illumina 450K BeadChips arrays (cg25932869), as well as contiguous CpGs. Graphical
representation from 3 representative heterozygous placenta samples with hap-ASM is shown. This region overlaps with the common
SNP, rs11761361. Allele A and B are analyzed and represented separately. The SNP dictates methylation level with the alternate allele
(allele B) being significantly hypermethylated compared to the reference allele (allele A), suggesting the presence of haplotype-
dependent ASM in 19 out of 21 heterozygous samples. The low methylated allele is significantly biased toward allele A (p = 10−06,
using binomial test) which ruled out imprinting. The hap-ASM overlaps with an insulator chromatin state (blue) in a NHEK cell line
which suggests the presence of a dynamic regulatory element. For each heterozygous sample, Wilcoxon p value and methylation
difference between alleles were calculated by bootstrapping (1,000 sampling of 20 reads per allele) and are indicated only for
significant hap-ASM defined as the difference in percentage methylation>20%,>3 ASM CpGs, and p< 0.05. One representative
random sample of each allele (20 reads per allele) is shown. mQTL, eQTL, and placenta chromatin states tracks are from our
analyses. The GWAS SNPs track was downloaded from the NHGRI-EBI GWAS Catalog [1], TF ChIP-seq data, DNAse I
hypersensitive sites and cell line chromatin states were downloaded from the ENCODE project [78]. ΔMeth (difference in the
percentage of methylation between alleles in heterozygous samples) and Wilcoxon p-values are from bootstrapping.
https://doi.org/10.1371/journal.pgen.1007785.g002
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regression slope<5% for 87% of the association). Due to the nature of the DNA methylation
signal, intermediate levels of methylation are likely to reflect cellular heterogeneity [27]. There-
fore, it is possible that mQTLs associations help to identify genetic variant impacting cell dif-
ferentiation mechanisms, expanding downstream functional consequences associated with
mQTLs.
To lay a groundwork for future studies on disease susceptibility, identification of biological
pathways associated with eQTLs and mQTLs are of interest. In this context, it is valuable to
identify pathways involving genes with greater sensitivity to genetic background. Therefore,
we looked at gene set enrichment for genes associated with an eQTL and the nearest gene
from CpG sites associated with a mQTL using the Bioconductor package GOseq [29]. For both
eQTLs and mQTLs, we found enrichment for inflammation related pathways (S14 Table)
suggesting that the variability captured by our associations may, in fact, reflect different
degrees of inflammatory response across our collected samples. It is also interesting to note
that the enrichment analysis outcomes (S14 Table) rely mainly on genes part of the major
histocompatibility complex (HLA-DRB1, HLA-DBR5, HLA-DQA1, HLA-DQB1, HLA-C).
These genes are known to be highly polymorphic with 13,840 different HLA alleles reported in
the IMGT/HLA database [43] suggesting polymorphism mechanism as a possible bias in QTL
Fig 3. Expression and methylation profiles associated with eQTLs and mQTLs. Enrichment for quartile of expression (A) or
DNA methylation (B) was assessed using permutation tests. The density plots represent the distribution of overlaps between
random sampling and the different quartiles whereas the red line illustrates the overlap value between candidate associations and
corresponding quartiles.
https://doi.org/10.1371/journal.pgen.1007785.g003
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and GWAS analysis. Finally, we decided to look into the overlap between the gene associated
with eQTLs and gene associated with mQTLs where CpG was associated to the closest gene.
We found 111 genes overlapping between the 2 associations (S15 Table) with pathway enrich-
ment only relying on HLA related genes.
Genetic variants associated with eQTLs and mQTLs
Genomic context is known to play a cell type-specific role in regulating transcription. To
determine whether genetic variation was occurring at regulatory sites, we took advantage of
public chromatin mapping data for placenta generated by the Roadmap Epigenomics Program
(S16 Table). The DNase hypersensitivity and ChIP-seq data create combinatorial patterns that
can help to define functional elements in the genome (S7 Fig) [44]. However, because placenta
specific reference datasets are limited and do not include data from term placenta, we were
compelled to build our genomic annotation based on data from the pre-term placenta which
may affect the accuracy of our annotation especially in a highly dynamic tissue like placenta.
For relative enrichment studies, the observed overlap between genetic variants and a genomic
feature was compared with the expected overlap given the total coverage of the annotation. For
permutation tests, we compared the observed overlap of SNPs significantly associated with
eQTLs (n = 608) or mQTLs (n = 3,022) and a particular genomic interval (for example gene
promoters, CpG islands) or feature from ChromHMM analysis with the distribution of the
same overlap under the null hypothesis.
SNPs associated with eQTLs and mQTLs were enriched in candidate promoters (Feature
1), candidate active and poised enhancers (Feature 2–4) and enriched at regions likely to be
transcribed (Feature 7) (Fig 4A and 4B). When looking at the distribution of the distance
between SNP and gene for eQTL association (n = 985) or SNP and CpG for mQTL association
(n = 4,342), we found enrichment for closest interactions (within 10Kb, S8 Fig) suggesting that
the associated genetic variant has an effect via its presence in proximal cis-regulatory elements.
We then explored the genomic context for CpGs (n = 4,342) associated with mQTLs and
found, as in our previous study of multiple human tissues [13], that they are enriched in candi-
date active and poised enhancers (Feature 2 and 3) (Fig 3C). This finding suggests a possible
cis-regulatory impact of mQTLs on gene expression.
Transcription factor binding sites enrichment analysis
Using combined genetic and epigenetic profiling applied to other human tissues, we and oth-
ers have found evidence that some of the epigenetic effects of genetic variation are mediated
by SNPs in insulator elements and transcription factor binding sites [13, 45–47]. Therefore, we
decided to analyze the impact of genetic variation on the integrity of the binding motif in cor-
relation with predicted binding affinities. Due to linkage disequilibrium, the index SNP may
not be causal, so we decided to also investigate the impact of previously identified SNPs in
proximity to the eQTL and mQTL associated gene TSS or CpG respectively (regardless of their
linkage disequilibrium status). This approach allows us to expand our discovery to transcrip-
tion factors likely to be affected by linked genetic variants. We compared the predicted binding
affinities between the reference and alternative alleles within a window of 39 bp around
each targeted genetic variant using the motif-based sequence analysis tools FIMO from the
MEME suite [48]. To assure the accessibility of the binding site, only those overlapping with
DNAse hypersensitive regions (ENCODE data, release 3) were considered for further analysis.
The analysis was performed at the motif level. The list of altered binding sites was further
pruned down based on 2 criteria (1) the significance of the binding with the reference allele
(q.value<0.05) and (2) the difference in binding affinity between the reference and alternative
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allele. Distributions of the difference of binding affinity between the reference and alternative
sequence were used to define the cutoff for predicted allele-specific binding (difference in
binding >8, S9 Fig). The significance of the alteration from our filter list of genetic variants
and transcription factor binding motif was assessed using atSNP [49]. atSNP performs compu-
tations for between-allele score differences [50] and outputs p.values for each targeted SNP
Fig 4. Genomic annotations of placental eQTLs and mQTLs. Bar graphs representing the observed versus expected ratio for each
feature define by ChromHMM analysis and from Refseq annotations. Grey filling represents enrichment that did not reach
significance (A). Significance was assessed using a permutation test. The density plots represent the distribution of overlaps between
random sampling and the different features whereas the red line illustrates the overlap value between candidate associations and the
corresponding features (B). eQTL-SNP refers to enrichment considering the genetic variant associated to eQTL, mQTL-SNP refers
to enrichment considering the genetic variant associated to the mQTL and mQTL-CpG refers to enrichment considering the CpG
associated to the mQTL.
https://doi.org/10.1371/journal.pgen.1007785.g004
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and selected transcription factor binding motif. The complete list of affected transcription fac-
tor binding sites is in S17 Table.
Interestingly, when looking at transcription factor binding sites associated with mQTLs a
significant number have been previously associated with alterations of the epigenetic landscape
(CTCF, REST, HDAC2, EWSR1, FLI1, SP4/1 and BHLHE40). CTCF (CCCTC-binding factor)
previously identified as associated with mQTLs and haplotype-dependent allele-specific meth-
ylation (hap-ASM) by Do et al. [13] is one of the best documented transcription factors affect-
ing DNA methylation. CTCF, which acts to anchor high-order chromatin loops and binds at
some of its recognition sites in a CpG methylation-dependent manner, is known to have an
essential role in imprinting control achieving allele-specific gene regulation [51] and CTCF
binding locally influences DNA methylation [52]. REST (REI-silencing transcription factor)
inactivation has been shown using a transgenic approach to induce de novo methylation and
conversely, the expression of REST was sufficient to restore the unmethylated state of the
DNA sequence bound [52]. Direct association between HDAC2 (Histone deacetylase 2),
EWSR1 (Ewing sarcoma breakpoint region1), FLI1, SP4/1 and BHLHE40 (Basic helix-loop-
helix family member E40) and changes in DNA methylation have not yet been demonstrated
but they have been previously associated with changes in histone methylation or acetylation
[53–57]. Numerous evidence supports a complex interplay between histone modification and
DNA methylation (for review [58, 59]). However, if in numerous contexts a bidirectional asso-
ciation between changes in DNA methylation and histone modifications has been reported,
the exact mechanism involved still needs to be identified. Interestingly, these associations
seemed to not only rely on direct interaction between DNMT enzymes and histone methyl-
transferases but also on the recruitment of a variety of intermediate factors such as member of
the SET domain family (G9a) or member of the Polycomb complex (PRC1) suggesting that a
large number of histone modification factors could indirectly affect DNA methylation. Among
the different transcription factor binding sites linked to eQTLs, we also found EWSR1, FLI1,
and SP4/1, suggesting that the effect of transcription factors on gene expression may be in part
mediated via epigenetic modifications. This list of transcription factors provides candidate
mechanisms to explain the association between genetic variants and gene expression or DNA
methylation.
Genetic variants linked to eQTLs or mQTLs and association with GWAS
peaks
The GWAS approach identifies disease-related enrichment for specific genetic variants. This
approach has considerably improved marker discovery but, because of linkage disequilibrium
among many SNPs in each chromosomal region, it has a limited ability to pinpoint disease
genes and regulatory sequence variants. “Post-GWAS” approaches that integrate eQTLs and
mQTLs to GWAS datasets can help to overcome these challenges [12]. For our current analy-
sis, we overlapped the genetic variants listed in the GWAS catalog [60] with those associated
with eQTLs (n = 608) and mQTLs (n = 3,022). Only 7 genetic variants associated with the pla-
cental eQTLs were previously found in GWAS peaks. Of these, three validated the previously
reported association between the genetic variant and gene in the GWAS database (S18 Table).
Two mQTLs shared a genetic variant with statistical peaks in the GWAS database (S19 Table).
The GWAS database references a limited number of studies involving trait directly associated
with placenta function or dysfunction. We identified only 2 studies related to preeclampsia
and 6 related to birth weight and none of them appears in the overlaps with eQTLs and
mQTLs. Nonetheless, among these hits, some are found associated with traits that have been
previously linked to fetal growth, like obesity and type II diabetes where the placenta is likely
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to play a role. rs35694355 overlaps with our eQTLs and have been previously associated with
obesity. Interestingly, this genetic variant is associated with CRACR2B gene in the GWAS data-
base but with IRF7 in our eQTL study. Contrary to CRACR2B, evidence for a direct association
between IRF7 and obesity have been shown [61] with IRF7 knockout mouse being protected
from gain weight after high-fat diet exposure. IRF7 is also highly expressed in placenta and it
though to play a role in the immune barrier between the fetus and the mother [62]. Due to the
tight correlation between inflammatory response and obesity, IRF7 may appear as a better can-
didate to link rs35694355 with disease sensitivity. From our mQTL analysis, rs623323 has been
previously associated with Type 2 diabetes in the GWAS database. In both datasets, rs623323
was associated with NXN gene. Interestingly in a recent publication, increase of DNA methyla-
tion and decrease of expression for NXN has been characterized in placenta from women with
diabetes during pregnancy [63] suggesting that the presence of rs623323 may influence suscep-
tibility to type II diabetes via alteration of NXN function thus providing with a great example
of how integrative QTL analysis can provide with evidence to better understand disease
susceptibility.
Relationship of DNA methylation to gene expression
Being able to establish transcript-CpG specific associations (eQTMs) based on gene expression
and CpG DNA methylation at a genome-wide scale in a tissue specific manner will signifi-
cantly improve further interpretations of epigenetic modifications when considering their
functional implications. Using our transcriptomic and epigenomic data, we decided to identify
CpG methylation and gene expression with a significant correlation. To do so, we applied a
similar approach to the one used for eQTL analysis. Looking at different combinations of CpG
sites and transcripts with linear regression in a 100 kb window (matrixEQTL), we were able to
identify 55,492 eQTM associations, representing 47,140 unique CpG sites and 14,352 unique
genes. After permutation and quality control, 2,655 eQTM associations remained with 2,538
unique CpG sites and 1,269 genes (S20 Table). 515 associations were located in the sex chro-
mosomes. To make the analysis less computationally intensive, we decided to sample gene
expression profiles instead of CpG methylation profiles during permutation.
A genomic context-dependent correlation between DNA methylation and expression has
previously been shown [64]. Negative correlation, when an increase in DNA methylation is
associated with a decrease in expression, was found for CpG sites located in the promoter
region. A positive correlation, when an increase in DNA methylation is associated with an
increase of expression, was found for CpG sites located in the gene body. We first assessed if
such profiles were also found among our associations. Both negative and positive associations
were enriched for proximal interaction (Fig 5A). We then examined enrichment between our
newly annotated features specific to placenta and our eQTM candidates stratified based on
positive (n = 1,009) and negative (n = 1,646) correlations. We found the negative association
to be enriched for feature 1 (candidate promoter) and 2 (candidate active enhancer) and asso-
ciations with positive correlation to be enriched for feature 5 (Fig 5B). Unfortunately, feature 5
does not show a clear significant enrichment pattern for the interrogated histone marks (S7
Fig). However, looking at the distribution over Refseq annotations, we confirm the enrichment
for gene body region. This validates the inversely correlated relationship between DNA meth-
ylation and gene expression in promoter regions as well as the positive correlation when tar-
geting the gene body region.
To identify potential mechanisms underlying the correlation between DNA methylation
and expression, we assessed the role of transcription factors, looking at enrichment for specific
binding sites overlapping the CpG site from the eQTM associations (n = 2,655) using a similar
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approach as described above. The null distribution represents the sampling of CpGs (n =
1,000) from the population of all assayed CpGs overlapping with a specific TFBS. Associations
with negative correlation were found to be globally enriched for transcription factor binding
sites suggesting a general mechanism where increase DNA methylation at a given binding site
will alter binding abilities and affect transcription. Interestingly, when looking at associations
that showed a positive correlation between expression and DNA methylation, we found
Fig 5. Placenta-specific genomic annotations of eQTMs. The histogram represents the density of eQTM associations in function of
the distance from transcription start site (TSS) considering positive and negative correlation separately (A). The density plots
represent the distribution of overlaps between random sampling and the different features as defined by permutations tests whereas
the red line illustrates the overlap value between candidate associations and corresponding features (B).
https://doi.org/10.1371/journal.pgen.1007785.g005
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enrichment for only one transcription factor, ZNF217 (S21 Table). The ZNF217 transcription
factor has been previously recognized as a human oncogene and is known to be part of a com-
plex that contains several histone-modifying enzymes strongly associated with gene repression
[13]. Thus, alteration of the binding of this transcription factor is predicted to disturb the for-
mation of a gene repression complex and lead to an increase of expression for the targeted
gene by diminishing its inhibition. There is also evidence for a more distal action of ZNF217
with only 2% of the binding site within a 1 kb distance from TSS [13].
When looking at the pattern for correlation between DNA methylation and expression, we
identified two distinct profiles. We found eQTM associations with a linear distribution
between methylation and expression representing a range of continuous values for both DNA
methylation and gene expression and, at other loci, associations with a bimodal distribution
with no intermediate values for both DNA methylation and gene expression (Fig 6). Because
DNA methylation is a binary variable as mentioned before, having eQTM associations with
bimodal distribution suggest that every interrogated cell within the placenta sample share the
Fig 6. Linear and bimodal correlations among eQTMs. Representation of linear and bimodal distributions for DNA methylation
and expression (A). Scatter plot representing the correlation between DNA methylation and expression among the samples for
selected top candidates associations (B). The red line represents the linear regression for each association.
https://doi.org/10.1371/journal.pgen.1007785.g006
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same DNA methylation and expression profiles, implying that the association is non cell- or
state-specific. On the contrary, eQTM associations with linear distribution suggest a cell- or
state-specific mechanism where the continuous signal is explained by the distribution of cells
being fully or not methylated among the placenta sample (S10 Fig). To assign eQTMs to linear
or bimodal distribution we implemented a Bayesian model for bimodal distribution detection.
Each gene expression or DNA methylation distribution was analyzed separately and eQTMs
were called as linear if both expression and methylation represented a linear distribution and
called bimodal if both expression and methylation show a bimodal distribution profile (see
Methods).
Using our model, we classified 118 associations as bimodal including 29 unique genes and
108 unique CpG sites, and 1,201 as linear which represent 877 unique genes and 1,140 unique
CpG sites (Fig 6, S22 Table). The greater occurrence of linear correlations can be attributed to
the high cellular heterogeneity of the placenta. Both linear and bimodal associations were
enriched for proximal interactions, with linear showing a more spread distribution (Fig 7A).
Interestingly, linear and bimodal distributed associations were not found enriched for the
same genomic context, linear distributed eQTMs were enriched for feature 2 and 3, our candi-
date active and poised enhancer and bimodally distributed eQTMs where enriched for feature
1 our candidate promoter (Fig 7B).
Looking at transcription factor binding sites across bimodal and linear eQTM associations,
we identified a specific pattern where bimodal but not linear associations were globally
enriched in transcription factor binding sites (S21 Table). Interestingly, the transcription
factor previously identified as part of the bHLH family (MAX, MAZ, MXI1, MYC, and
SIN3aK20) where highly enriched for bimodally distributed associations while depleted for
linear associations (S11 Fig). This suggests that distribution not only reflect cell heterogeneity
but also provide information on the different factors involved in DNA methylation regulation
of expression. These observations, if not sufficient to propose a definitive mechanism of action,
will definitely contribute as key resources to further analysis when linking DNA methylation
alteration to phenotypes by offering a curated list of gene sensitive to methylation alterations
specific to the placenta.
Discussion
The results presented here highlight the importance of genetic-epigenetic interactions in
human placentas and provide a resource to further characterize the dynamic of these interac-
tions in the context of human diseases. Indeed, because GWAS and EWAS analyses are statisti-
cal approaches that only report associations between genetic variants and interrogated
phenotypes, an approach in which GWAS data are combined with reference datasets detailing
associations between genetic variants and gene expression or CpG methylation can help to
pinpoint genes and regulatory DNA sequence variants linked to disease susceptibility. By pro-
viding a curated list of eQTL, mQTL, and eQTM associations, with careful consideration of
potential false-positive and false-negative findings, we have started to address these issues as
they pertain to human placentas. Our data represent an initial basis for understanding how
genetic variation in human placentas influences epigenetics marks and expression and allows
the identification of genes and CpG sites with greater sensitivity to genetic variants, which
should be considered when interpreting disease-focused studies such as GWAS and EWAS.
Indeed, a significant amount of research today is built on the dichotomy between treated ver-
sus non-treated or disease versus non-diseased with less consideration toward understanding
what constitutes normal or healthy. Thus, our ability to more fully define a ‘normal’ molecular
phenotype will have a notable impact on the interpretation and significance of such studies.
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Fig 7. Differences in genomic distribution between linear and bimodal eQTMs. The histogram represents the
density of eQTM associations in function of the distance from transcription start site (TSS) considering linear and
bimodal correlation separately (A). The density plots represent the distribution of overlaps between random sampling
and the different features as defined by permutations tests whereas the red line illustrates the overlap value between
candidate associations and features (B).
https://doi.org/10.1371/journal.pgen.1007785.g007
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Lastly, a better understanding of the interplay between the multiple functional layers at a sys-
tems level under normal conditions is needed to fully benefit from the ever-increasing amount
of multi–omic data.
Epigenome-wide association studies, primarily focusing on DNA methylation, have been
used for examining the impact of environmental exposures and early biomarker discovery
[13]. The increasing number of studies and challenges in this area have been reviewed [65].
Among these challenges is the ability to adequately correlate DNA methylation and expression
profiles to identify reliable and causal associations in a tissue-specific context. Here, we provide
a list of candidate genes and CpG sites with high genetic-epigenetic correlations in human pla-
centas, revealing some general principles of these interactions. Associations found in promoter
regions represent a categorical/bimodal signal with enrichment for transcription factor bind-
ing sites, while enhancer interactions represent a linear additive profile with no significant
enrichment for transcription factors. These differences can be related to cell heterogeneity.
Indeed, promoter regions show a more constitutive pattern across cell types while enhancers
are more likely to be cell type specific. Therefore, enhancer regions will present a cell specific
signal depicted as a continuous range of values for gene expression and DNA methylation
which transcribe as a linear distribution when looking at methylation-expression associations.
Cell subpopulation effects are now recognized as a major source of variability and support the
recommendation for single cell type analysis in EWAS [4]. The placenta is a highly heteroge-
neous tissue and demonstrates differences in gene expression and DNA methylation, which
may be due to changes in the proportional distribution of different cell types (for example, as a
result of infection, inflammation or other conditions) that can later confound methylation-dis-
ease associations [66]. Heterogeneity may be corrected using statistical deconvolution tech-
niques [67, 68] where a subset of targets is used to represent distinct DNA methylation or gene
expression profiles for each cell type and assess subpopulation distribution. The accuracy of
these approaches is highly dependent on the availability of reference epigenomes and tran-
scriptomes and the ability to select representative targets for the tissue considered. Single cell
data for the placenta are not available. However, genes and CpG sites with linear distribution
can be further used to assess and control for cell subtype population in human placenta.
There are several strengths to our study, the most important of which is the comprehensive
nature of our analysis. By sampling more than 300 individual placentas from an ethnically
diverse and representative population, we present here the most extensive placenta-specific
genome-wide analysis published to date. Based on our heterogeneous population we believe
that our findings will be applicable to populations with diverse backgrounds including minori-
ties that have been so far underrepresented in both GWAS and EWAS studies. Another key
factor of our study is the resolution of our approach. We combine from the same cohort
genome-wide transcriptome, epigenome and genetic variation information which allows for
improved understanding of the intricacy of expression regulation mechanisms in an under-
studied tissue by overcoming the limitations inherent to each individual dataset when consid-
ered separately. Finally, the ability to extract meaningful information is highly dependent on
the quality of the analytical approach. Thus, we describe here stringent methods to incorporate
different datasets and extract robust correlations. We also emphasize the limitations intrinsic
to the different techniques, which will help to assure reproducibility.
A major gap in the field has been the lack of placenta-specific annotations. This situation
also makes our findings valuable as they will promote the creation of a placenta-specific data
repository. We believe that the massive amount of high-quality data generated will serve as a
reference and benefit to further–omics placenta specific studies and contribute to a new per-
spective in term of disease susceptibility and placenta development.
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Methods
Ethics statement
This study has been approved by the Columbia University IRB Exp. The protocol number is
IRB-AAAD9014. Written informed consent were obtained for all women at time of the
enrollment.
Study participants
Subjects and samples were identified from the Eunice Kennedy Shriver National Institute of
Child Health and Human Development (NICHD) Fetal Growth Study, which was a prospec-
tive, multicentered, observational study including 3,000 pregnant women [69]. Healthy, non-
obese, low risk pregnant women across four race/ethnicity groups, who conceived spontane-
ously and had no obvious risk factors for fetal growth restriction or overgrowth were eligible
for inclusion in the study. Specifically, self-identified non-Hispanic white, African-American,
Hispanic, and Asian/Pacific Islander women with a singleton pregnancy less than 13 weeks
and 6 days of gestation were enrolled. All women were between 18 and 40 years old with BMI
between 19.0 to 29.9kg/m2 with no confirmed or suspected fetal congenital structural or chro-
mosomal anomalies. Multiple exclusions were identified to assure a low risk population and
included but was not limited to, cigarette smoking in the past six months, use of illicit drugs in
the past year, consumption of at least 1 alcoholic drink per day, chronic hypertension, diabetes
mellitus, HIV or AIDS, and history of gestational diabetes in a prior pregnancy. To assure cor-
rect dating, all pregnancies had first trimester ultrasound screening consistent with gestational
age. Placentas were collected from pregnancies with a predicted birthweight by ultrasound
between the 10th and the 90th percentile (S23 Table).
Sample collection
Placental samples were obtained and processed within one hour of delivery by trained research
personnel. Placental parenchymal biopsies measuring 0.5 cm x 0.5 cm x 0.5 cm were taken
from the fetal side of the placenta just beneath the fetal membranes and were placed in RNA-
Later and frozen for molecular analysis.
After delivery, neonatal anthropometric measurements were taken. These included: birth
weight, head circumference. Information on maternal weight gain, antenatal and intrapartum
complications, and neonatal outcomes were extracted from the medical record.
Genome-wide gene expression
RNA from 80 placenta biopsies (42 males and 38 females) was isolated using TRIZOL reagent
(Invitrogen, MA, USA). Poly-A pull-down was used to enrich for mRNAs, and libraries were
prepared using the Illumina TruSeq RNA kit. Libraries were pooled and sequenced on an Illu-
mina HiSeq2000 machine with 100 bp paired-end reads. RTA (Illumina, San Diego, CA, USA)
was used for base calling and bcl2fastq (version 1.8.4) for converting BCL to FASTQ format,
coupled with adaptor trimming. The reads were mapped to the human reference genome
(NCBI/build37.2) using Tophat (version 2.0.4) with 4 mismatches (—read-mismatches = 4)
and 10 maximum multiple hits (—max-multihits = 10). The relative expression level of genes
was estimated by FPKM (Fragments Per Kilobase of transcript per Million mapped reads)
using cufflinks (version 2.0.2) with default settings. FPKM values were used in log2-trans-
formed scale after quantile normalization. Data are available through dbGap repository, acces-
sion number: phs001717.v1.p1.
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Genome-wide DNA methylation
Genomic DNA from 303 placental biopsies (151 males and 152 females), 500 ng, was used as
per the manufacturer’s instructions for HumanMethylation 450 Beadchips (Illumina), with all
assays performed at the Roswell Park Cancer Institute (RPCI) Genomics Shared Resource.
Data were processed using Genome Studio, which calculates the fractional methylation
(AVG_Beta) at each queried CpG, after background correction, normalization to internal con-
trol probes, and quantile normalization. All probes mapping to the X or Y chromosome were
removed. As recommended by Illumina, AVG_Beta values with a detection p-value>0.05
were excluded from the analysis and replaced by missing values. Probes that queried CpGs
directly overlapping the positions of known common DNA variants as reported in 1000
Genomes Project Phase 3 (allele frequency >1%) and within a 20 base pair window upstream
of the interrogated CpG were excluded since these CpGs may be abolished by the SNP itself or
the binding of the probe itself could be altered [34]. Additionally, the accuracy of the Illumina
450K can be affected by cross-reactive probes that were also excluded from our analysis [35].
Data are available through dbGap repository, accession number: phs001717.v1.p1.
Genome-wide SNP genotyping
The DNA samples (n = 303, 151 males, and 152 females) were genotyped on Illumina Huma-
nOmni2.5 Beadchips, followed by initial data processing using Genome Studio. SNPs were
annotated using dbSNP138. Quality control exclusionary measures for subjects were: genotype
call rates <95%, marked departure from Hardy-Weinberg equilibrium (p<0.001) and low
minor allele frequencies <5% after QC filtering genotype was conserved for 1,374,581 SNPs.
Data are available through dbGap repository, accession number: phs001717.v1.p1.
Association analyses and FDR control
To test for association between genotype and expression (each SNP vs each transcript, eQTL)
or genotype and DNA methylation (each SNP vs each methylation site, mQTL) we used a lin-
ear regression model implemented in QTLtools [70]. For the association between expression
and DNA methylation (each transcript vs each methylation site, eQTM) we used a linear
regression model (LINEAR) implemented in Matrix eQTL [71]. For eQTL and eQTM, the lin-
ear regression model was corrected using principal component analysis (PCA) and PEER nor-
malization (K = 10) based on expression data [72]. For PCA analysis, only the principal
components (PC) significantly contributing to variability were added into the model. In our
case, PC1 and PC2 were included as contributing for up to 32% of variability (S2 Fig). For
PEER analysis, covariate contribution was estimated using Bayesian approaches to infer
hidden determinants and their effects from gene expression profiles by using factor analysis
methods [72]. For each association, FDR was estimated by permutations a 1,000 times after
correction for multiple comparisons using Benjamini & Hochberg [73] approach implemented
in R package (p.adjust). The same random indexes were applied to the PEER factors and
covariates. For eQTLs and mQTLs, permutation is implemented in the QTLtools package. For
expression-methylation associations (eQTMs), we permuted ratio for each transcript with sig-
nificant association (n = 14,353) 1,000 times. For eQTL analysis, the correlation was run
between expression and genotype across 80 samples (42 male, 38 female), for mQTL analysis
association between methylation and genotype was calculated across 303 samples (151 male,
152 female) and for eQTM analysis through 74 samples (38 male, 36 female).
Associations reaching the significance threshold were retained to further analysis if having
at least a shared genotype in 5% or more individuals (AA, AB, BB, where A is the reference
and B the alternate allele) and regression slope>5%. Associations were further prioritized
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based on their regression slope and distance between a genetic variant and associated gene or
CpG to encompass the linearity and the magnitude of the progression between the different
genotype. Briefly, we generated a score for each association following this equation [score =
(1-P.value)�abs(regression slope)/log(abs(distance)+2)].
Determination of “at-risk” probes
“At-risk” probes were defined following 3 distinct criteria (1) the presence of common SNPs
in a 20 bp window from the 3’ end of Illumina probe (SNP-probe) [34], (2) previous identifica-
tion as cross-reactive probes [35] and (3) based on a specific methylation profile using Gap-
Hunter algorithm (gap-probe) [36]. Criteria 1 and 2 were sufficient to exclude the probe from
further analysis while criteria 3 only resulted in a flagging of the identified probes. We first
identified all CpG-SNPs interrogated by the Illumina 450k assay based on 1000 Genomes Proj-
ect Phase 3 dataset using an allele frequency >1%. We then used the same reference to identify
probe with known genetic variants within the 20 bp upstream of the interrogated CpGs includ-
ing the single base extension for probe of type I. We decided to consider 20 bp because of the
absence of consensus for exclusion and because we did not detect a differential enrichment
from 20 bp to the 5’ end of the probe (S12 Fig). This list of affected probes was further pruned
down by excluding probes containing a genetic variant with reference and alternative alleles
involving a C or a T which will not affect the binding of the probe as we are considering bisul-
fite-treated reads. The list of cross-reactive probes is publicly available [35]. We used the func-
tion “gaphunter” from the minfi package (v1.18.4) to identify probes with a gap in a beta
signal. Such probe signal has a tendency to be driven by an underlying SNP or other genetic
variants. Beta values were provided as input and the function outcomes a data frame listing for
each identified gap signal, the number of groups and the size of each group. Only gap signals
not driven by outlier (cutoff = 1%) were considered. A complete list of SNP-probe, cross-reac-
tive probe as well as gap-probe is available as S7 Table. S7 Table also includes the list of associa-
tion involving a gap-probes. Finally, the non filtered list of mQTLs with annotated probes
(SNP/cross-reactive/Gap-probes) is available at S13 Table.
Enrichment analysis
For an observed overlap X between our candidates and a list of intervals of interest Y of size n
from a total population of assayed sites Z, we compared the observed value of X with the distri-
bution of the same overlap n under the null hypothesis using permutation tests. To obtain the
null distribution, we employed a random sampling approach where we randomly sampled
1,000 times from the population of all assayed sites (Z). Thus, with Y, n, and an observed over-
lap with a genomic interval, X, we sampled n loci from Z and found the overlap of the random
sample with the interval, Yk, for k in 1, 2, . . ., 1000 (that is 1000 random samples). Next, we
compared X with the distribution of simulated overlaps, Y1,2,. . .,1000. If the resulting null distri-
bution, Y1,2,. . .,1000, contains the observed overlap, X, then we can conclude that there is no sig-
nificant enrichment. Conversely, when the null distribution, Y1,2,. . .,1000, excludes the observed
overlap, X, then we can conclude that there is significant enrichment beyond that of random
chance. The significance is further assigned as follow: the number of time when Yk > X
divided by k.
π1 statistics
The π1 statistic was used to quantify overlap between eQTL associations found in placenta and
the tissue cataloged by the GTEx consortium. The non–model-based pairwise analysis method
identifies significant SNP-gene pairs in a first tissue, and then uses the distribution of the P
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values for these pairs in the second tissue to estimate π1, the proportion of non-null associa-
tions in the second tissue. It provides an estimate of the fraction of true positive eQTLs,
π1 = 1-π0, where π0 = estimated fraction of null eQTLs, estimated from the full distribution of
p-values (Storey and Tibshirani q-value approach [74]). The π1 statistic considers also sub-
threshold placenta eQTL p-values below the FDR<5% cutoff.
Transcription factor binding affinity estimate
Using the 1000 Genomes Project Phase 3 dataset, we identified all genetic variants within 2 kb
windows centered on the gene transcription start site (eQTL) or CpG (mQTL) using a minor
allele frequency >1%. The transcription factor dataset was from ENCODE ChIP-seq experi-
ments, together with DNA bindings motifs identified within these regions as displayed by the
ENCODE Factorbook repository [75]. We first compare transcription factor binding affinity
between the reference and alternative allele using the FIMO tools in the MEME suite [48].
FIMO is a software tool for scanning DNA or protein sequences with motifs described as posi-
tion-specific scoring matrices. The program computes a log-likelihood ratio score for each
position in a given sequence database, uses established dynamic programming methods to
convert this score to a P-value and then applies false discovery rate analysis to estimate a q-
value for each position in the given sequence. FIMO output a list of significant binding site for
both reference and alternative allele. However, FIMO only provides with qualitative informa-
tion and does not allow for significant quantification of the difference in binding affinity
between the two alleles. Therefore, we used atSNP [49] to quantify the difference between the
reference and alternative allele for the binding site identified by FIMO. It uses ENCODE
motifs and JASPAR motifs to evaluate the regulatory potential of the SNPs. It outputs for
each SNP the significance of the match to each position specific matrix with both the reference
and the alternative allele and also the significance of the change in these match scores. atSNP
relies on sampling algorithm with a first-order Markov model for the background nucleotide
sequences to test the significance of affinity score and SNP-driven changes in these scores.
atSNP is an R package.
Pathways analysis
For pathways analysis, we used the Bioconductor package GOseq [29] combined with the
KEGG annotation database [76]. GOseq is based on gene ontology analysis but allows for cor-
rection such as gene length that has been shown to bias gene set enrichment analysis. For
eQTL associations, we control for gene length as implemented in the reference manual and for
mQTL associations, we generated a list of the number of probes per genes using Illumina
450K and Refseq annotations. This list was then used as input to control for gene overrepre-
sentation bias.
Genome annotation
Placenta specific genome annotation has been generated using publicly available data from the
Roadmap in Epigenomics project. Chromatin immunoprecipitation followed by massively
parallel sequencing (ChIP-seq) was obtained from fetal placenta primary tissue from several
donors (S16 Table). Annotation involved processing the raw data for chromatin accessibility
(DNase hypersensitivity) along with ChIP-seq data for six histone modifications (H3K4me1,
H3K27me3, H3K27ac, H3K4me3, H3K36me3 and H3K9me3), followed by the use of the
ChromHMM algorithm [77] to predict seven features as previously described. ChromHMM is
based on a multivariate hidden Markov model that models the observed combination of chro-
matin marks using a product of independent Bernoulli random variables, which enables robust
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learning of complex patterns of many chromatin modifications. ChromHMM outputs both
the learned chromatin-state model parameters and the chromatin-state assignments for each
genomic position. Based on enrichment and genomic localization, feature 1 was annotated as
candidate promoter (H3K4me3), feature 2 as candidate active enhancer (H3K4me1 and
H3k27ac), feature 3 and 4 as candidate poised enhancer (H3K4me1 and H3k27me3) and fea-
ture 7 as transcribed sequences (H3K36me3). Finally, features 5 and 6 did not show enough
specific enrichment to be annotated (S7 Fig).
Targeted bisulfite sequencing
Targeted bis-seq was performed for the validation of 3 mQTL regions and to assess the effect
of common SNPs in 4 Illumina probes as described in Do et al. [13]. Briefly, the primers (S24
Table) were designed using MethPrimer. Bisulfite-converted DNA was amplified by PCR, fol-
lowed by Nextgen sequencing (Illumina MiSeq). The PCR and library preparation were per-
formed using Fluidigm Access Array system. PCRs were performed in triplicate and pooled to
ensure sequence complexity. ASM was assessed when the coverage was at least 100 DNA frag-
ments. While the absolute differences between methylation of the two alleles are not exagger-
ated by ultra deep sequencing, the p-values tend to zero as the number of reads increases.
Therefore, the Wilcoxon non parametric test was performed using bootstrapping (1000 ran-
dom samplings, 20 reads per allele) to minimize an artificially low p-value due to ultra deep
coverage. The significance of the allele asymmetry was defined by p<0.05 and an absolute
methylation difference between allele>20%. For the graphical representations of the bis-seq,
one representative random sampling of the reads was shown per allele. Samplings and boot-
strapping were performed using R.
Assessment of the association’s distribution
First, we assessed unimodal and bimodal distribution for expression and methylation data. For
expression, a Bayesian model of normal distribution was used to estimate the parameters of
the normal distribution fitting the data. The likelihood function is given by a normal distribu-
tion:
expi � dnormðm; tÞ
Here, expi is the expression value for the ith sample. μ denotes the mean of the normal distribu-
tion, τ is the precision of the normal distribution. Standard deviation s ¼ 1ffiffi
t
p .
The prior for the parameter μ and τ are described by two non-informative priors as:
m � dnormð0; 0:0001ÞIð0; Þ
t � dgammað0:01; 0:01Þ
Here, the prior for the μ is distributed on the right side of a normal distribution with mean 0
and standard deviation 100. The prior for the precision is described as a gamma distribution
with mean 1 and standard deviation 10. To assess the bimodal distribution of expression data,
a mixture of two normal distributions model was used to estimate the means, standard devia-
tion and the mass of the bimodal distribution.
The likelihood function can be written as:
expi � o1dnormðm1; tÞ þ o2dnormðm2; tÞ
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Here, ω1 and ω2 represent the mass of each mixture. μ1 and μ2 are the means of each mixture.
We assumed that the two mixtures have similar variance, τ.
The prior for the mass ω1 is described as:
o1 � dbetað1; 1Þ½0:1; 0:9�
o1 þ o2 ¼ 1
Here, the prior of the mass for the first mixture follows a uniform beta distribution ranging
from 0.1 to 0.9, which means the proportion for any mixture has to be larger than 10%. And
the two mixtures add up to 1.
The prior for the means μ1 and μ2 are described the same way as the mean in a unimodal
model.
Because the methylation value for CpG site ranging from 0 to 1, we used a beta distribution
to describe the unimodal distribution of the methylation data instead of the normal
distribution.
Likelihood:
methyi � dbetaða; bÞ
Here, methyi is the methylation value for the ith sample.
The parameters of the beta distribution α and β are determined by μ, the mean of the meth-
ylation data, and κ, the variation of the methylation data, as:
a ¼ m � k
b ¼ ð1   mÞ � k
The priors for μ and κ are modeled as:
m � dbetað1; 1Þ
k � dgammað0:01; 0:01Þ
Here, μ follows a non-informative uniform beta distribution, and κ follows a gamma
distribution.
For bimodal distribution of methylation data, a mixture of two beta distributions was used.
The likelihood:
methyi � o1dbetaða1 ¼ m1k;b1 ¼ ð1   m1ÞkÞ þ o2dbetaða2 ¼ m2k; b2 ¼ ð1   m2ÞkÞ
Here, ω1 and ω2 represent the mass of each mixture. μ1 and μ2 are the means of each mixture.
We assume that the two mixtures have similar variance, κ.
The prior for the mass ω1 is described as:
o1 � dbetað1; 1Þ½0:2; 0:8�
o1 þ o2 ¼ 1
Here, the prior of the mass for the first mixture follows a uniform beta distribution ranging
from 0.2 to 0.8, which means the proportion for any mixture has to be larger than 20%. And
the two mixtures add up to 1.
The prior for the means μ1 and μ2 are described the same way as described in unimodal
methylation data.
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Having both the model and data, we used the Gibbs Sampler JAGS (Martyn Plummer
2003) to sample the posterior distribution through the “rjags” package (Martyn Plummer
2016). Finally, we compared the goodness of fit of a unimodal and bimodal model for the data
by Bayesian Information Criteria (BIC). The unimodality or bimodality of the data is deter-
mined by the model with better BIC. The mean and standard deviation of the data is estimated
from the posterior distribution sampled by JAGS.
Codes used during our analysis are available here: [https://github.com/fabiendelahaye/
Placenta_analysis.git]
Supporting information
S1 Fig. Cohort description. Heatmap representing gene expression correlation across samples
for the full dataset (ALL) and highly variable genes defined using MAD (High MAD) (A).
Heatmap representing DNA methylation correlation across samples for the full dataset (ALL)
and highly variable genes defined using MAD (High MAD) (B). Genetic background analysis
using principal component. Each plot represents principal component 1 versus principal
component 2 when considering the 1000 genomes samples reference dataset (1000 Genomes
Project samples), our placenta cohort (Placenta Samples) and the overlap between the two.
Populations are color coded in the reference dataset and black squares represent samples from
the placenta cohort (C).
(TIF)
S2 Fig. Identification of cofounders. The principal component analysis was run to identify
cofounders within the gene expression and DNA methylation datasets. Histogram represent-
ing the proportion of variance explains for each principal component from 1 to 10 (A). Associ-
ation between principal component and the known factor was assessed using linear regression.
Heatmap representing the level of significance for the association between a principal compo-
nent and each factor for gene expression dataset (B) and DNA methylation dataset (C).
(TIF)
S3 Fig. Representative association for eQTLs and mQTLs. Boxplot representing the profile
of expression for each genotype for selected top candidate eQTLs (A). Boxplot representing
the profile of methylation for each genotype for selected top candidate mQTLs (B).
(TIF)
S4 Fig. The overlap between placenta specific association and GTEx dataset. Histogram
representing the enrichment for cis-eQTLs from the placenta in transformed fibroblasts from
GTEx (A) and in brain cerebellar hemisphere (B). The π1 value represents similarity between
tissue ranging from 0 (least similar) to 1 (most similar).
(TIF)
S5 Fig. mQTL validation. Targeted bis-seq data showing Hap-ASM in LOC01848 region. The
bis-seq amplicon covers the mQTL index CpG (cg15548566), as well as contiguous CpGs. This
region overlaps with the common SNP, rs13360436 which dictates methylation level with the
alternate allele (allele B) being significantly hypermethylated compared to the reference allele
(allele A), suggesting the presence of hap-ASM in 11 out of 19 heterozygous samples. The low
methylated allele is significantly biased toward allele A (p = 4x10-06, using binomial test) which
ruled out imprinting. In this region, rs112724034 has been associated with Alzheimer’s disease
(AD) [1]. ΔMeth (difference in the percentage of methylation between alleles in heterozygous
samples) and Wilcoxon p-values are from bootstrapping.
(TIF)
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S6 Fig. Example of false-negative in our stringent mQTL set. Bis-seq showing hap-ASM in
CLDN23 region. cg24900164 was excluded from our main analysis since the probe maps a
common non-CT SNP located 7 bp from the index CpG and was therefore not included in our
stringent mQTL list. However, targeted bis-seq identified hap-ASM dictated by rs13254997 in
9 out of 20 heterozygous samples (7 positives and 2 negative hap-ASM). In addition, the net
methylation estimates from Illumina 450K BeadChips arrays and bis-seq were similar suggest-
ing that the SNP did not affect the probe hybridization. These findings suggest the presence of
genuine mQTL at this locus.
(TIF)
S7 Fig. ChromHMM annotations. ChromHMM algorithm was used to define genomic
annotations based on ChIP-seq tracks available for the placenta. Heatmap representing the
enrichment for the different ChIP-seq mark in each feature (A). Heatmap representing the
enrichment for previously defined genomic annotation in each feature (B). Density plot repre-
senting the enrichment for each feature in function of the distance from the transcription
starting site (TSS) (C).
(TIF)
S8 Fig. Enrichment for proximal associations. Histogram representing the distribution of
associations from the transcription start site (TSS) for eQTL (A) and from the CpG site for
mQTL (B).
(TIF)
S9 Fig. Distribution of difference in binding affinity. Representative density plot of the dif-
ference in binding affinity between the reference and alternative allele for eQTL (A) and
mQTL (B) as defined by FIMO. Null differences and binding not reaching a p.value <0.0001
were excluded prior to analysis.
(TIF)
S10 Fig. Schematic representation of the subpopulation effect on the correlation between
DNA methylation and gene expression. Scenario representing a correlation between CpG
and gene which is not cell specific as DNA methylation and gene expression profiles are
similar across the different cells of each sample. CpG is either fully or not methylated and
expression is high or low. This scenario will be called as bimodal distribution (A). Scenario
representing an absence of correlation between DNA methylation and gene expression (B).
Scenario representing a correlation between CpG and gene which is cell specific as DNA meth-
ylation and gene expression profiles are variable across cell within each sample. This profile
will be called a linear distribution (C).
(TIF)
S11 Fig. Transcription factor binding sites enrichment for eQTMs. The density plots repre-
sent the distribution of overlaps between random sampling and the selected transcription fac-
tors binding site as defined by the ENCODE Factorbook repository when the red line
illustrates the overlap value between candidate associations and the corresponding transcrip-
tion factor binding site for linear (A) and bimodal (B) distributions.
(TIF)
S12 Fig. mQTL association within Illumina 450k probes. Scatter plot representing the
enrichment for significant associations in function of distance from 3’end of Illumina probe.
The blue dash line represents the cutoff use during our study. This cutoff was defined based on
previous observations and on the decrease, enrichment observed in our analysis.
(TIF)
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S1 Table. Correlation of expressions between placenta and Tissue from the GTEx consor-
tium.
(XLSX)
S2 Table. Summary of genes with high variability across the placenta.
(XLSX)
S3 Table. Summary of CpGs with high variability across the placenta.
(XLSX)
S4 Table. Summary of pathways associated with gene showing high variability. This table
relates the significant outcome of the gene set enrichment analysis using GOseq and KEGG
database for genes and CpG-associated genes classified as high variable across placenta using
MAD.
(XLSX)
S5 Table. Summary of eQTL associations.
(XLSX)
S6 Table. Summary of mQTL associations.
(XLSX)
S7 Table. Excluded probes. This table recapitulates the list of probes from Illumina 450K
design that were excluded in the present analysis, the list of cross-reactive probes as defined by
Chen YA, et al., the list of probes that were flagged by Gap-hunter as well as the list of mQTLs
and eQTMs that match with these flagged probes.
(XLSX)
S8 Table. Summary of genes associated with eQTL overlapping with the previously pub-
lished association by Peng et al.
(XLSX)
S9 Table. mQTL association overlapping with previously identify mQTLs in the Do et al.
paper. The overlap between our candidate mQTLs and the one previously identified by Do
et al. was generated focusing on mQTL associated CpG.
(XLSX)
S10 Table. π1 score across the GTEx tissues. π1 was calculated for each available sample from
the GTEx database as a measure of similarity between these tissues and placenta.
(XLSX)
S11 Table. List of placenta specific associations.
(XLSX)
S12 Table. mQTLs validation. The outcome of the validation using a targeted approach for
selected mQTL candidate found in our and Do et al. studies.
(XLSX)
S13 Table. The complete list of mQTL associations with flagged at “risk” probes.
(XLSX)
S14 Table. KEGG analysis. This table relates the significant outcome of the gene set enrich-
ment analysis using GOseq and KEGG database for eQTL and mQTL associations.
(XLSX)
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S15 Table. List of genes overlapping between eQTLs and mQTLs.
(XLSX)
S16 Table. ChromHMM input dataset. Information regarding placenta specific ChIP-seq
tracks used to perform ChromHMM.
(XLSX)
S17 Table. List of the transcription factor with altered binding affinity due to genetic vari-
ants associated to eQTLs and mQTLs. This list represents the outcome of the atSNP algo-
rithm.
(XLSX)
S18 Table. The overlap between placenta specific eQTLs and associations from the GWAS
database. This analysis was centered on overlapping genetic variants between placenta eQTLs
and genetic variant previously reported in the GWAS database.
(XLSX)
S19 Table. The overlap between placenta specific mQTLs and associations from the GWAS
database. This analysis was centered on overlapping genetic variants between placenta
mQTLs and genetic variant previously reported in the GWAS database.
(XLSX)
S20 Table. Summary of eQTM associations.
(XLSX)
S21 Table. Transcription binding sites analysis for eQTM associations. List of transcription
factor binding sites showing significant enrichment for eQTM candidates considering
bimodal, linear distribution and positive or negative correlation separately.
(XLSX)
S22 Table. Summary of eQTM association based on the correlation distribution profile.
(XLSX)
S23 Table. Cohort information.
(XLSX)
S24 Table. List of primers for bis-seq validation.
(XLSX)
Acknowledgments
SNP genotyping and methylation Beadchip assays were performed by the Genomics Shared
Resource of Roswell Park Cancer Institute.
Author Contributions
Conceptualization: Fabien Delahaye, Francine Hughes.
Data curation: Fabien Delahaye.
Formal analysis: Fabien Delahaye, Yu Kong.
Funding acquisition: Ben Tycko, Ronald Wapner.
Investigation: Fabien Delahaye.
Methodology: Fabien Delahaye, Catherine Do, Remi Ashkar, Martha Salas.
Functional genomic characterization of the human placenta
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1007785 November 19, 2018 29 / 34
Project administration: Ronald Wapner.
Resources: Ronald Wapner.
Supervision: Fabien Delahaye, Ben Tycko, Ronald Wapner, Francine Hughes.
Validation: Catherine Do.
Writing – original draft: Fabien Delahaye.
Writing – review & editing: Fabien Delahaye, Catherine Do, Ben Tycko, Ronald Wapner,
Francine Hughes.
References
1. MacArthur J, Bowler E, Cerezo M, Gil L, Hall P, Hastings E, Junkins H, McMahon A, Milano A, Morales
J, et al: The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog).
Nucleic Acids Res 2017, 45:D896–D901. https://doi.org/10.1093/nar/gkw1133 PMID: 27899670
2. Stranger BE, Stahl EA, Raj T: Progress and promise of genome-wide association studies for human
complex trait genetics. Genetics 2011, 187:367–383. https://doi.org/10.1534/genetics.110.120907
PMID: 21115973
3. Visscher PM, Brown MA, McCarthy MI, Yang J: Five years of GWAS discovery. Am J Hum Genet 2012,
90:7–24. https://doi.org/10.1016/j.ajhg.2011.11.029 PMID: 22243964
4. Michels KB, Binder AM, Dedeurwaerder S, Epstein CB, Greally JM, Gut I, Houseman EA, Izzi B, Kelsey
KT, Meissner A, et al: Recommendations for the design and analysis of epigenome-wide association
studies. Nat Methods 2013, 10:949–955. https://doi.org/10.1038/nmeth.2632 PMID: 24076989
5. Consortium GT, Laboratory DA, Coordinating Center -Analysis Working G, Statistical Methods groups-
Analysis Working G, Enhancing Gg, Fund NIHC, Nih/Nci, Nih/Nhgri, Nih/Nimh, Nih/Nida, et al: Genetic
effects on gene expression across human tissues. Nature 2017, 550:204–213. https://doi.org/10.1038/
nature24277 PMID: 29022597
6. Feil R, Fraga MF: Epigenetics and the environment: emerging patterns and implications. Nat Rev
Genet 2012, 13:97–109. https://doi.org/10.1038/nrg3142 PMID: 22215131
7. Petronis A: Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature
2010, 465:721–727. https://doi.org/10.1038/nature09230 PMID: 20535201
8. Bell JT, Spector TD: DNA methylation studies using twins: what are they telling us? Genome Biol 2012,
13:172. https://doi.org/10.1186/gb-2012-13-10-172 PMID: 23078798
9. Kaminsky ZA, Tang T, Wang SC, Ptak C, Oh GH, Wong AH, Feldcamp LA, Virtanen C, Halfvarson J,
Tysk C, et al: DNA methylation profiles in monozygotic and dizygotic twins. Nat Genet 2009, 41:240–
245. https://doi.org/10.1038/ng.286 PMID: 19151718
10. Ollikainen M, Smith KR, Joo EJ, Ng HK, Andronikos R, Novakovic B, Abdul Aziz NK, Carlin JB, Morley
R, Saffery R, Craig JM: DNA methylation analysis of multiple tissues from newborn twins reveals both
genetic and intrauterine components to variation in the human neonatal epigenome. Hum Mol Genet
2010, 19:4176–4188. https://doi.org/10.1093/hmg/ddq336 PMID: 20699328
11. Grundberg E, Meduri E, Sandling JK, Hedman AK, Keildson S, Buil A, Busche S, Yuan W, Nisbet J,
Sekowska M, et al: Global analysis of DNA methylation variation in adipose tissue from twins reveals
links to disease-associated variants in distal regulatory elements. Am J Hum Genet 2013, 93:876–890.
https://doi.org/10.1016/j.ajhg.2013.10.004 PMID: 24183450
12. Do C, Shearer A, Suzuki M, Terry MB, Gelernter J, Greally JM, Tycko B: Genetic-epigenetic interactions
in cis: a major focus in the post-GWAS era. Genome Biol 2017, 18:120. https://doi.org/10.1186/
s13059-017-1250-y PMID: 28629478
13. Do C, Lang CF, Lin J, Darbary H, Krupska I, Gaba A, Petukhova L, Vonsattel JP, Gallagher MP, Goland
RS, et al: Mechanisms and Disease Associations of Haplotype-Dependent Allele-Specific DNA Methyl-
ation. Am J Hum Genet 2016, 98:934–955. https://doi.org/10.1016/j.ajhg.2016.03.027 PMID:
27153397
14. Li J, Liu S, Li S, Feng R, Na L, Chu X, Wu X, Niu Y, Sun Z, Han T, et al: Prenatal exposure to famine
and the development of hyperglycemia and type 2 diabetes in adulthood across consecutive genera-
tions: a population-based cohort study of families in Suihua, China. Am J Clin Nutr 2017, 105:221–227.
https://doi.org/10.3945/ajcn.116.138792 PMID: 27927634
15. Barker DJ, Thornburg KL: Placental programming of chronic diseases, cancer and lifespan: a review.
Placenta 2013, 34:841–845. https://doi.org/10.1016/j.placenta.2013.07.063 PMID: 23916422
Functional genomic characterization of the human placenta
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1007785 November 19, 2018 30 / 34
16. Barker DJ, Thornburg KL: The obstetric origins of health for a lifetime. Clin Obstet Gynecol 2013,
56:511–519. https://doi.org/10.1097/GRF.0b013e31829cb9ca PMID: 23787713
17. Barker DJ, Larsen G, Osmond C, Thornburg KL, Kajantie E, Eriksson JG: The placental origins of sud-
den cardiac death. Int J Epidemiol 2012, 41:1394–1399. https://doi.org/10.1093/ije/dys116 PMID:
22997261
18. Filiberto AC, Maccani MA, Koestler D, Wilhelm-Benartzi C, Avissar-Whiting M, Banister CE, Gagne LA,
Marsit CJ: Birthweight is associated with DNA promoter methylation of the glucocorticoid receptor in
human placenta. Epigenetics 2011, 6:566–572. https://doi.org/10.4161/epi.6.5.15236 PMID:
21521940
19. Nelissen EC, van Montfoort AP, Dumoulin JC, Evers JL: Epigenetics and the placenta. Hum Reprod
Update 2011, 17:397–417. https://doi.org/10.1093/humupd/dmq052 PMID: 20959349
20. Sood R, Zehnder JL, Druzin ML, Brown PO: Gene expression patterns in human placenta. Proc Natl
Acad Sci U S A 2006, 103:5478–5483. https://doi.org/10.1073/pnas.0508035103 PMID: 16567644
21. Storvik M, Huuskonen P, Pehkonen P, Pasanen M: The unique characteristics of the placental tran-
scriptome and the hormonal metabolism enzymes in placenta. Reprod Toxicol 2014, 47:9–14. https://
doi.org/10.1016/j.reprotox.2014.04.010 PMID: 24814680
22. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM,
et al: Human DNA methylomes at base resolution show widespread epigenomic differences. Nature
2009, 462:315–322. https://doi.org/10.1038/nature08514 PMID: 19829295
23. Peng S, Deyssenroth MA, Di Narzo AF, Lambertini L, Marsit CJ, Chen J, Hao K: Expression quantitative
trait loci (eQTLs) in human placentas suggest developmental origins of complex diseases. Hum Mol
Genet 2017, 26:3432–3441. https://doi.org/10.1093/hmg/ddx265 PMID: 28854703
24. Visscher PM, Wray NR, Zhang Q, Sklar P, McCarthy MI, Brown MA, Yang J: 10 Years of GWAS Dis-
covery: Biology, Function, and Translation. Am J Hum Genet 2017, 101:5–22. https://doi.org/10.1016/j.
ajhg.2017.06.005 PMID: 28686856
25. Bustamante CD, Burchard EG, De la Vega FM: Genomics for the world. Nature 2011, 475:163–165.
https://doi.org/10.1038/475163a PMID: 21753830
26. Need AC, Goldstein DB: Next generation disparities in human genomics: concerns and remedies.
Trends Genet 2009, 25:489–494. https://doi.org/10.1016/j.tig.2009.09.012 PMID: 19836853
27. Wijetunga NA, Delahaye F, Zhao YM, Golden A, Mar JC, Einstein FH, Greally JM: The meta-epige-
nomic structure of purified human stem cell populations is defined at cis-regulatory sequences. Nat
Commun 2014, 5:5195. https://doi.org/10.1038/ncomms6195 PMID: 25327398
28. Geeleher P, Hartnett L, Egan LJ, Golden A, Raja Ali RA, Seoighe C: Gene-set analysis is severely
biased when applied to genome-wide methylation data. Bioinformatics 2013, 29:1851–1857. https://
doi.org/10.1093/bioinformatics/btt311 PMID: 23732277
29. Young MD, Wakefield MJ, Smyth GK, Oshlack A: Gene ontology analysis for RNA-seq: accounting for
selection bias. Genome Biol 2010, 11:R14. https://doi.org/10.1186/gb-2010-11-2-r14 PMID: 20132535
30. Poschl E, Schlotzer-Schrehardt U, Brachvogel B, Saito K, Ninomiya Y, Mayer U: Collagen IV is essen-
tial for basement membrane stability but dispensable for initiation of its assembly during early develop-
ment. Development 2004, 131:1619–1628. https://doi.org/10.1242/dev.01037 PMID: 14998921
31. Chen CP, Aplin JD: Placental extracellular matrix: gene expression, deposition by placental fibroblasts
and the effect of oxygen. Placenta 2003, 24:316–325. PMID: 12657504
32. Zhang X, Moen EL, Liu C, Mu W, Gamazon ER, Delaney SM, Wing C, Godley LA, Dolan ME, Zhang W:
Linking the genetic architecture of cytosine modifications with human complex traits. Hum Mol Genet
2014, 23:5893–5905. https://doi.org/10.1093/hmg/ddu313 PMID: 24943591
33. Shi J, Marconett CN, Duan J, Hyland PL, Li P, Wang Z, Wheeler W, Zhou B, Campan M, Lee DS, et al:
Characterizing the genetic basis of methylome diversity in histologically normal human lung tissue. Nat
Commun 2014, 5:3365. https://doi.org/10.1038/ncomms4365 PMID: 24572595
34. Zhi D, Aslibekyan S, Irvin MR, Claas SA, Borecki IB, Ordovas JM, Absher DM, Arnett DK: SNPs located
at CpG sites modulate genome-epigenome interaction. Epigenetics 2013, 8:802–806. https://doi.org/
10.4161/epi.25501 PMID: 23811543
35. Chen YA, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW, Gallinger S, Hudson TJ,
Weksberg R: Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium Human-
Methylation450 microarray. Epigenetics 2013, 8:203–209. https://doi.org/10.4161/epi.23470 PMID:
23314698
36. Andrews SV, Ladd-Acosta C, Feinberg AP, Hansen KD, Fallin MD: "Gap hunting" to characterize clus-
tered probe signals in Illumina methylation array data. Epigenetics Chromatin 2016, 9:56. https://doi.
org/10.1186/s13072-016-0107-z PMID: 27980682
Functional genomic characterization of the human placenta
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1007785 November 19, 2018 31 / 34
37. Pierce BL, Tong L, Argos M, Demanelis K, Jasmine F, Rakibuz-Zaman M, Sarwar G, Islam MT, Shah-
riar H, Islam T, et al: Co-occurring expression and methylation QTLs allow detection of common causal
variants and shared biological mechanisms. Nat Commun 2018, 9:804. https://doi.org/10.1038/
s41467-018-03209-9 PMID: 29476079
38. Chen L, Ge B, Casale FP, Vasquez L, Kwan T, Garrido-Martin D, Watt S, Yan Y, Kundu K, Ecker S,
et al: Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune Cells. Cell 2016,
167:1398–1414 e1324. https://doi.org/10.1016/j.cell.2016.10.026 PMID: 27863251
39. McClay JL, Shabalin AA, Dozmorov MG, Adkins DE, Kumar G, Nerella S, Clark SL, Bergen SE, Swed-
ish Schizophrenia C, Hultman CM, et al: High density methylation QTL analysis in human blood via
next-generation sequencing of the methylated genomic DNA fraction. Genome Biol 2015, 16:291.
https://doi.org/10.1186/s13059-015-0842-7 PMID: 26699738
40. Hannon E, Spiers H, Viana J, Pidsley R, Burrage J, Murphy TM, Troakes C, Turecki G, O’Donovan MC,
Schalkwyk LC, et al: Methylation QTLs in the developing brain and their enrichment in schizophrenia
risk loci. Nat Neurosci 2016, 19:48–54. https://doi.org/10.1038/nn.4182 PMID: 26619357
41. Banovich NE, Lan X, McVicker G, van de Geijn B, Degner JF, Blischak JD, Roux J, Pritchard JK, Gilad
Y: Methylation QTLs are associated with coordinated changes in transcription factor binding, histone
modifications, and gene expression levels. PLoS Genet 2014, 10:e1004663. https://doi.org/10.1371/
journal.pgen.1004663 PMID: 25233095
42. Smith AK, Kilaru V, Kocak M, Almli LM, Mercer KB, Ressler KJ, Tylavsky FA, Conneely KN: Methyla-
tion quantitative trait loci (meQTLs) are consistently detected across ancestry, developmental stage,
and tissue type. BMC Genomics 2014, 15:145. https://doi.org/10.1186/1471-2164-15-145 PMID:
24555763
43. Robinson J, Halliwell JA, Hayhurst JD, Flicek P, Parham P, Marsh SG: The IPD and IMGT/HLA data-
base: allele variant databases. Nucleic Acids Res 2015, 43:D423–431. https://doi.org/10.1093/nar/
gku1161 PMID: 25414341
44. Hoffman MM, Buske OJ, Wang J, Weng Z, Bilmes JA, Noble WS: Unsupervised pattern discovery in
human chromatin structure through genomic segmentation. Nat Methods 2012, 9:473–476. https://doi.
org/10.1038/nmeth.1937 PMID: 22426492
45. Chen K, Rajewsky N: The evolution of gene regulation by transcription factors and microRNAs. Nat Rev
Genet 2007, 8:93–103. https://doi.org/10.1038/nrg1990 PMID: 17230196
46. Zhu H, Wang G, Qian J: Transcription factors as readers and effectors of DNA methylation. Nat Rev
Genet 2016, 17:551–565. https://doi.org/10.1038/nrg.2016.83 PMID: 27479905
47. Maurano MT, Wang H, John S, Shafer A, Canfield T, Lee K, Stamatoyannopoulos JA: Role of DNA
Methylation in Modulating Transcription Factor Occupancy. Cell Rep 2015, 12:1184–1195. https://doi.
org/10.1016/j.celrep.2015.07.024 PMID: 26257180
48. Cuellar-Partida G, Buske FA, McLeay RC, Whitington T, Noble WS, Bailey TL: Epigenetic priors for
identifying active transcription factor binding sites. Bioinformatics 2012, 28:56–62. https://doi.org/10.
1093/bioinformatics/btr614 PMID: 22072382
49. Zuo C, Shin S, Keles S: atSNP: transcription factor binding affinity testing for regulatory SNP detection.
Bioinformatics 2015, 31:3353–3355. https://doi.org/10.1093/bioinformatics/btv328 PMID: 26092860
50. Chan HP, Zhang NR, Chen LH: Importance sampling of word patterns in DNA and protein sequences. J
Comput Biol 2010, 17:1697–1709. https://doi.org/10.1089/cmb.2008.0233 PMID: 21128856
51. Ohlsson R, Renkawitz R, Lobanenkov V: CTCF is a uniquely versatile transcription regulator linked to
epigenetics and disease. Trends Genet 2001, 17:520–527. PMID: 11525835
52. Stadler MB, Murr R, Burger L, Ivanek R, Lienert F, Scholer A, van Nimwegen E, Wirbelauer C, Oakeley
EJ, Gaidatzis D, et al: DNA-binding factors shape the mouse methylome at distal regulatory regions.
Nature 2011, 480:490–495. https://doi.org/10.1038/nature10716 PMID: 22170606
53. Kanda M, Yamanaka H, Kojo S, Usui Y, Honda H, Sotomaru Y, Harada M, Taniguchi M, Suzuki N,
Atsumi T, et al: Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of IFN-
gamma production in iNKT cells. Proc Natl Acad Sci U S A 2016, 113:E3394–3402. https://doi.org/10.
1073/pnas.1604178113 PMID: 27226296
54. Tomazou EM, Sheffield NC, Schmidl C, Schuster M, Schonegger A, Datlinger P, Kubicek S, Bock C,
Kovar H: Epigenome mapping reveals distinct modes of gene regulation and widespread enhancer
reprogramming by the oncogenic fusion protein EWS-FLI1. Cell Rep 2015, 10:1082–1095. https://doi.
org/10.1016/j.celrep.2015.01.042 PMID: 25704812
55. Benveniste D, Sonntag HJ, Sanguinetti G, Sproul D: Transcription factor binding predicts histone modi-
fications in human cell lines. Proc Natl Acad Sci U S A 2014, 111:13367–13372. https://doi.org/10.
1073/pnas.1412081111 PMID: 25187560
Functional genomic characterization of the human placenta
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1007785 November 19, 2018 32 / 34
56. Gilbert N, Thomson I, Boyle S, Allan J, Ramsahoye B, Bickmore WA: DNA methylation affects nuclear
organization, histone modifications, and linker histone binding but not chromatin compaction. J Cell Biol
2007, 177:401–411. https://doi.org/10.1083/jcb.200607133 PMID: 17485486
57. Rountree MR, Bachman KE, Herman JG, Baylin SB: DNA methylation, chromatin inheritance, and can-
cer. Oncogene 2001, 20:3156–3165. https://doi.org/10.1038/sj.onc.1204339 PMID: 11420732
58. Rose NR, Klose RJ: Understanding the relationship between DNA methylation and histone lysine meth-
ylation. Biochim Biophys Acta 2014, 1839:1362–1372. https://doi.org/10.1016/j.bbagrm.2014.02.007
PMID: 24560929
59. Cedar H, Bergman Y: Linking DNA methylation and histone modification: patterns and paradigms. Nat
Rev Genet 2009, 10:295–304. https://doi.org/10.1038/nrg2540 PMID: 19308066
60. Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H, Klemm A, Flicek P, Manolio T, Hindorff
L, Parkinson H: The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic
Acids Res 2014, 42:D1001–1006. https://doi.org/10.1093/nar/gkt1229 PMID: 24316577
61. Wang XA, Zhang R, Zhang S, Deng S, Jiang D, Zhong J, Yang L, Wang T, Hong S, Guo S, et al: Inter-
feron regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance. Am J Physiol
Endocrinol Metab 2013, 305:E485–495. https://doi.org/10.1152/ajpendo.00505.2012 PMID: 23695216
62. Kim J, Zhao K, Jiang P, Lu ZX, Wang J, Murray JC, Xing Y: Transcriptome landscape of the human pla-
centa. BMC Genomics 2012, 13:115. https://doi.org/10.1186/1471-2164-13-115 PMID: 22448651
63. Alexander J, Teague AM, Chen J, Aston CE, Leung YK, Chernausek S, Simmons RA, Pinney SE: Off-
spring sex impacts DNA methylation and gene expression in placentae from women with diabetes dur-
ing pregnancy. PLoS One 2018, 13:e0190698. https://doi.org/10.1371/journal.pone.0190698 PMID:
29470513
64. Wagner JR, Busche S, Ge B, Kwan T, Pastinen T, Blanchette M: The relationship between DNA methyl-
ation, genetic and expression inter-individual variation in untransformed human fibroblasts. Genome
Biol 2014, 15:R37. https://doi.org/10.1186/gb-2014-15-2-r37 PMID: 24555846
65. Birney E, Smith GD, Greally JM: Epigenome-wide Association Studies and the Interpretation of Disease
-Omics. PLoS Genet 2016, 12:e1006105. https://doi.org/10.1371/journal.pgen.1006105 PMID:
27336614
66. Koestler DC, Marsit CJ, Christensen BC, Accomando W, Langevin SM, Houseman EA, Nelson HH,
Karagas MR, Wiencke JK, Kelsey KT: Peripheral blood immune cell methylation profiles are associated
with nonhematopoietic cancers. Cancer Epidemiol Biomarkers Prev 2012, 21:1293–1302. https://doi.
org/10.1158/1055-9965.EPI-12-0361 PMID: 22714737
67. Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH, Wiencke JK,
Kelsey KT: DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinfor-
matics 2012, 13:86. https://doi.org/10.1186/1471-2105-13-86 PMID: 22568884
68. Abbas AR, Wolslegel K, Seshasayee D, Modrusan Z, Clark HF: Deconvolution of blood microarray data
identifies cellular activation patterns in systemic lupus erythematosus. PLoS One 2009, 4:e6098.
https://doi.org/10.1371/journal.pone.0006098 PMID: 19568420
69. Buck Louis GM, Grewal J, Albert PS, Sciscione A, Wing DA, Grobman WA, Newman RB, Wapner R,
D’Alton ME, Skupski D, et al: Racial/ethnic standards for fetal growth: the NICHD Fetal Growth Studies.
Am J Obstet Gynecol 2015, 213:449 e441-449 e441. https://doi.org/10.1016/j.ajog.2015.08.032 PMID:
26410205
70. Delaneau O, Ongen H, Brown AA, Fort A, Panousis NI, Dermitzakis ET: A complete tool set for molecu-
lar QTL discovery and analysis. Nat Commun 2017, 8:15452. https://doi.org/10.1038/ncomms15452
PMID: 28516912
71. Shabalin AA: Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics 2012,
28:1353–1358. https://doi.org/10.1093/bioinformatics/bts163 PMID: 22492648
72. Stegle O, Parts L, Piipari M, Winn J, Durbin R: Using probabilistic estimation of expression residuals
(PEER) to obtain increased power and interpretability of gene expression analyses. Nat Protoc 2012,
7:500–507. https://doi.org/10.1038/nprot.2011.457 PMID: 22343431
73. Benjamini Y, and Hochberg Yosef: Controlling the False Discovery Rate: A Practical and Powerful
Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological) 1995,
vol. 57:pp. 289–300.
74. Storey JD, Tibshirani R: Statistical significance for genomewide studies. Proc Natl Acad Sci U S A
2003, 100:9440–9445. https://doi.org/10.1073/pnas.1530509100 PMID: 12883005
75. Wang J, Zhuang J, Iyer S, Lin X, Whitfield TW, Greven MC, Pierce BG, Dong X, Kundaje A, Cheng Y,
et al: Sequence features and chromatin structure around the genomic regions bound by 119 human
transcription factors. Genome Res 2012, 22:1798–1812. https://doi.org/10.1101/gr.139105.112 PMID:
22955990
Functional genomic characterization of the human placenta
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1007785 November 19, 2018 33 / 34
76. Kanehisa M, Goto S: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000,
28:27–30. PMID: 10592173
77. Ernst J, Kellis M: ChromHMM: automating chromatin-state discovery and characterization. Nat Meth-
ods 2012, 9:215–216. https://doi.org/10.1038/nmeth.1906 PMID: 22373907
78. Ding N, Qu H, Fang X: [The ENCODE project and functional genomics studies]. Yi Chuan 2014,
36:237–247. PMID: 24846964
Functional genomic characterization of the human placenta
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1007785 November 19, 2018 34 / 34
